XML 88 R81.htm IDEA: XBRL DOCUMENT v3.25.3
Net Income (Loss) Per Share - Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - shares
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Stock Options    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of loss per share amount [1] 0 3,059,061
Restricted Stock    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of loss per share amount [1] 0 2,629,026
Series A-2 Preferred Stock    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of loss per share amount [1] 5,353,478 4,448,404
Stock Appreciation Rights (SARs)    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of loss per share amount [1] 0 3,000,000 [2]
[1] Includes 2,950,220 and 7,891,144 common stock equivalents that are out of the money as of September 30, 2025 and September 30, 2024, respectively.
[2] 2021 Performance SARs were cancelled effective as of December 31, 2024.